000			02148 a2200637 4500
005			20250517081413.0
264		0	_c20161031
008			201610s 0 0 eng d
022			_a1936-2625
040			_aNLM _beng _cNLM
100	1		_aGong, Qi-Xing
245	0	0	_aPrevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases. _h[electronic resource]
260			_bInternational journal of clinical and experimental pathology _c2015
300			_a15825-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAsian People
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aCD5 Antigens _xanalysis
650	0	4	_aChina
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKi-1 Antigen _xanalysis
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xchemistry
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aPrevalence
650	0	4	_aProto-Oncogene Proteins c-bcl-2
650	0	4	_aProto-Oncogene Proteins c-myc
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aRituximab
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xtherapeutic use
650	0	4	_aYoung Adult
700	1		_aLu, Ting-Xun
700	1		_aLiu, Chong
700	1		_aWang, Zhen
700	1		_aLiang, Jin-Hua
700	1		_aXu, Wei
700	1		_aLi, Jian-Yong
700	1		_aZhang, Zhi-Hong
700	1		_aChen, Qi
773	0		_tInternational journal of clinical and experimental pathology _gvol. 8 _gno. 12 _gp. 15825-35
999			_c25740470 _d25740470